Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 28.7 | 24.1 | 18.8 | 26.2 |
| Revenue growth | 19.0% | 27.9% | -28.0% | |
| Cost of goods sold | 14.6 | 12.2 | 9.1 | 12.4 |
| Gross profit | 14.1 | 11.9 | 9.8 | 13.8 |
| Gross margin | 49.0% | 49.3% | 51.9% | 52.6% |
| Selling, general and administrative | 35.1 | 36.5 | 18.0 | 28.5 |
| EBITA | -22.0 | -25.4 | -9.0 | -18.1 |
| EBITA margin | -76.6% | -105.5% | -48.0% | -69.3% |
| Amortization of intangibles | 0.4 | 0.4 | 0.4 | 0.3 |
| EBIT | -22.4 | -25.9 | -9.5 | -18.5 |
| EBIT margin | -78.1% | -107.3% | -50.2% | -70.5% |
| Pre-tax income | -0.6 | -37.7 | -10.9 | -10.9 |
| Income taxes | 0.0 | 0.1 | 0.1 | 0.0 |
| Net income | -0.6 | -37.7 | -11.0 | -11.0 |
| Net margin | -2.2% | -156.5% | -58.3% | -41.9% |
| |
| Diluted EPS | ($0.03) | ($4.28) | ($479.47) | ($10,982.00) |
| Shares outstanding (diluted) | 21.1 | 8.8 | 0.0 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|